focus -WSS

focus

author：explore 2025-08-12 08:28:26 - browse：37379

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Judge rejects Trump's request to move Stormy Daniels hush

focus

WSS

Affordable Connectivity Program vital to health care, experts say

Why Congress must ban federal programs from using QALYs

Weight loss drug costs may need more research, senator suggests

Hospitals struggle to profit from CAR

Why medical students are struggling with mental health

Astellas still sees hope in its gene therapy after four deaths

knowledge

focus

focus

Medicare details structure of new drug price negotiation program

Anthos stroke drug appears safer than common blood thinner

Apple is now the first public company to be valued at $3 trillion

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Affirmative action in medical school literally saved lives

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Hepatitis C has a cure — but many Americans still lack access to it

PBM reforms clear House panel

Heart attack and stroke risk calculators need revising

Surge of respiratory disease in China has likely explanation

knowledge

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Tocagen's brain cancer gene therapy trial continues. Investors worry

NYU radiologists take on the challenge of expensive MRI machines

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Indian pharmaceutical industry in denial over drug

entertainment

focus

hotspot

knowledge